Home
Conditions
Hepadnaviridae Infections

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies

Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

NCT00136604

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +22 more
Locations: GSK Investigational Site Bangkok, Thailand

GSK Investigational Site Khon Kaen, Thailand

GSK Investigational Site Songkhla, Thailand

View Trial Details

Completed

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

NCT00228917

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +22 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

GSK Investigational Site Bangkok, Thailand

View Trial Details

Completed

Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen

NCT01524679

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Facharztpraxis Prof. Löhr Wiesbaden, Hesse, Germany

Universitätsklinikum Aachen, Medizinische Klinik III Aachen, Germany

Leber- und Studienzentrum am Checkpoint Berlin, Germany

Charité Campus Virchow Klinikum, Universitätsmedizin Berlin Berlin, Germany

View all 24 locations

View Trial Details

Completed

The Relationship Between Vitamin D and Hepatitis B Virus Replication

NCT03068767

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation New Taipei City, Taiwan

View Trial Details

Completed

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV

NCT02751996

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Spring Bank Pharma Research site Calgary, Alberta, Canada

Spring Bank Pharma Research site Vancouver, British Columbia, Canada

Spring Bank Pharma Research Site London, Ontario, Canada

Spring Bank Pharma Research site Toronto, Ontario, Canada

View all 17 locations

View Trial Details

Completed

Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

NCT04264312

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Xicheng District Center for Disease Prevention and Control Beijing, Beijing Municipality, China

Huairou District Center for Disease Prevention and Control Beijing, Beijing Municipality, China

Daxing District Center for Disease Prevention and Control Beijing, Beijing Municipality, China

Chaoyang District Center for Disease Control and Prevention Beijing, Beijing Municipality, China

View Trial Details

Completed

Off Treatment Durability in Chronic Hepatitis B With Good Immune Control

NCT02738554

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Department of Medicine, The University of Hong Kong, Queen Mary Hospital Hong Kong

View Trial Details

Completed

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

NCT02081469

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Chang Gung Memorial Hospital Taipei, Taiwan

View Trial Details

Completed

Hepatitis B Virus Prevalence and Risk Factors in Belgium

NCT03425513

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Ziekenhuis Oost-Limburg Genk, Limburg, Belgium

View Trial Details

Completed

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

NCT01171989

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations: GSK Investigational Site Bydgoszcz, Poland

GSK Investigational Site Dębica, Poland

GSK Investigational Site Krakow, Poland

GSK Investigational Site Krakow, Poland

View Trial Details

Hepadnaviridae Infections

Hepadnaviridae Infections trial results

Related conditions